Health care costs and utilization for Alzheimer's disease patients

被引：0
|
作者：
Zhao, Y.
Kuo, T. C.
Weir, S.
Kramer, M. S.
Ash, A. S.
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] DxCG Inc, Boston, MA USA
[3] Univ Massachusetts, Sch Med, Shrewsbury, MA USA
[4] Boston Univ, Boston, MA 02215 USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68812-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A90 / A90
页数：1
相关论文
共 50 条
  • [41] Evaluation of full costs of care for patients with Alzheimer's disease in France: The predominant role of informal care
    Gerves, Chloe
    Chauvin, Pauline
    Bellanger, Martine Marie
    HEALTH POLICY, 2014, 116 (01) : 114 - 122
  • [42] Health Care Utilization Patterns and Costs for Patients With Hidradenitis Suppurativa
    Kirby, Joslyn S.
    Miller, Jeffery J.
    Adams, David R.
    Leslie, Douglas
    JAMA DERMATOLOGY, 2014, 150 (09) : 937 - 944
  • [43] THE CARE PROCESS OF ALZHEIMER'S DISEASE PATIENTS AND THEIR CAREGIVERS IN PRIMARY HEALTH CARE IN ROMANIA
    Busneag, Carmen
    Busneag, Razvan
    SGEM 2016, BK 1: PSYCHOLOGY AND PSYCHIATRY, SOCIOLOGY AND HEALTHCARE, EDUCATION CONFERENCE PROCEEDINGS, VOL I, 2016, : 367 - 374
  • [44] REAL-WORLD HEALTH CARE RESOURCE UTILIZATION AND COSTS OF HUNTINGTON'S DISEASE IN ISRAEL
    Ribalov, R.
    Yaari, A.
    Chodick, G.
    Barer, Y.
    VALUE IN HEALTH, 2020, 23 : S627 - S627
  • [45] Disease progression and costs of care in Alzheimer's disease patients treated with donepezil: a longitudinal naturalistic cohort
    Gustavsson, Anders
    Jonsson, Linus
    Parmler, Johan
    Andreasen, Niels
    Wattmo, Carina
    Wallin, Asa K.
    Minthon, Lennart
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (05): : 561 - 568
  • [46] Disease progression and costs of care in Alzheimer’s disease patients treated with donepezil: a longitudinal naturalistic cohort
    Anders Gustavsson
    Linus Jönsson
    Johan Parmler
    Niels Andreasen
    Carina Wattmo
    Åsa K. Wallin
    Lennart Minthon
    The European Journal of Health Economics, 2012, 13 : 561 - 568
  • [47] Patient-reported utilization of health care resources in ulcerative colitis and Crohn's disease matches their health care costs
    Odes, Selwyn H.
    Vardi, Hillel
    Friger, Michael
    Munkholm, Pia S.
    Stockbrugger, Reinhold W.
    Bernkley, Tomm
    Moum, Bjorn
    GASTROENTEROLOGY, 2008, 134 (04) : A199 - A200
  • [48] Implications of comorbidity on costs for patients with Alzheimer's disease
    Kuo, T. C.
    Zhao, Y.
    Weir, S.
    Kramer, M. S.
    Ash, A. S.
    VALUE IN HEALTH, 2007, 10 (03) : A93 - A93
  • [49] Estimates of health-care and societal costs as a function of pre-institutionalisation time in patients with Alzheimer's disease dementia
    Reed, C.
    Belger, M.
    Haro, J. M.
    Dell'Agnello, G.
    Wimo, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 528 - 528
  • [50] HEALTH CARE COSTS BY LEVEL OF ADHERENCE FOR INFLIXIMAB PATIENTS WITH CROHN'S DISEASE
    Michels, S.
    Eyck, Ten L.
    Vanderpoel, J.
    Lofland, J.
    Ingham, M.
    Uribe, C.
    Denny, L.
    VALUE IN HEALTH, 2014, 17 (03) : A39 - A39
12345